IL163696A0 - Hfa-suspension formulation of an anhydrate - Google Patents

Hfa-suspension formulation of an anhydrate

Info

Publication number: IL163696A0
Authority: IL; Israel
Prior art keywords: hfa; anhydrate; suspension formulation; formulation; suspension
Prior art date: 2002-03-28

Application number

IL16369603A

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-28

Filing date

2003-03-20

Publication date

2005-12-18

2003-03-20 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2005-12-18 Publication of IL163696A0 publication Critical patent/IL163696A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

IL16369603A 2002-03-28 2003-03-20 Hfa-suspension formulation of an anhydrate IL163696A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10214264A DE10214264A1 (en)	2002-03-28	2002-03-28	HFA suspension formulations of an anhydrate
PCT/EP2003/002899 WO2003082244A2 (en)	2002-03-28	2003-03-20	Hfa-suspension formulation of an anhydrate

Publications (1)

Publication Number	Publication Date
IL163696A0 true IL163696A0 (en)	2005-12-18

Family

ID=28050990

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16369603A IL163696A0 (en)	2002-03-28	2003-03-20	Hfa-suspension formulation of an anhydrate

Country Status (21)

Country	Link
EP (1)	EP1492498A2 (en)
JP (1)	JP5147158B2 (en)
KR (1)	KR101005717B1 (en)
CN (1)	CN1642525A (en)
AU (1)	AU2003221509B2 (en)
BR (1)	BR0308709A (en)
CA (1)	CA2479638C (en)
DE (1)	DE10214264A1 (en)
EA (1)	EA008610B1 (en)
EC (1)	ECSP045322A (en)
HR (1)	HRP20040890A2 (en)
IL (1)	IL163696A0 (en)
ME (1)	ME00246B (en)
MX (1)	MXPA04009338A (en)
NO (1)	NO20044004L (en)
NZ (1)	NZ536030A (en)
PL (1)	PL371295A1 (en)
RS (1)	RS52481B (en)
UA (1)	UA79776C2 (en)
WO (1)	WO2003082244A2 (en)
ZA (1)	ZA200405637B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0611091A2 (en) *	2005-05-02	2010-08-03	Boehringer Ingelheim Int	crystalline forms of tiotropic bromide
JP5227790B2 (en) *	2005-05-02	2013-07-03	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	New crystalline tiotropium bromide
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
EP2435025B1 (en) *	2009-05-29	2016-07-06	Pearl Therapeutics, Inc.	Respiratory delivery of active agents
AU2015201037C1 (en) *	2009-05-29	2017-07-27	Pearl Therapeutics, Inc.	Respiratory delivery of active agents
AU2014228414B2 (en)	2013-03-15	2018-09-13	Pearl Therapeutics, Inc.	Methods and systems for conditioning of particulate crystalline materials
EP3515439B1 (en) *	2016-09-19	2021-12-15	Mexichem Fluor S.A. de C.V.	Pharmaceutical composition comprising tiotropium bromide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (en) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
PT1102579E (en) *	1998-08-04	2003-07-31	Jago Res Ag	MEDICINAL AEROSOL FORMULATIONS
GB0009592D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory combinations
GB0009606D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Therapeutic combinations
GB0009583D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory formulations
GB0009605D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Medicaments
DE10113366A1 (en) *	2001-03-20	2002-09-26	Boehringer Ingelheim Pharma	Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist
DE10111058A1 (en) *	2001-03-08	2002-09-12	Boehringer Ingelheim Pharma	New drug compositions based on anticholinergics and NK¶1¶ receptor antagonists
CA2436537C (en) *	2000-10-31	2009-05-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions comprising tiotropium salts and antihistamines

2002
- 2002-03-28 DE DE10214264A patent/DE10214264A1/en not_active Withdrawn
2003
- 2003-03-20 ME MEP-2008-473A patent/ME00246B/en unknown
- 2003-03-20 KR KR1020047015174A patent/KR101005717B1/en active IP Right Grant
- 2003-03-20 CA CA2479638A patent/CA2479638C/en not_active Expired - Fee Related
- 2003-03-20 EP EP03717219A patent/EP1492498A2/en not_active Withdrawn
- 2003-03-20 UA UA20041008758A patent/UA79776C2/en unknown
- 2003-03-20 JP JP2003579782A patent/JP5147158B2/en not_active Expired - Lifetime
- 2003-03-20 AU AU2003221509A patent/AU2003221509B2/en not_active Expired
- 2003-03-20 IL IL16369603A patent/IL163696A0/en unknown
- 2003-03-20 EA EA200401159A patent/EA008610B1/en unknown
- 2003-03-20 BR BR0308709-3A patent/BR0308709A/en active Pending
- 2003-03-20 MX MXPA04009338A patent/MXPA04009338A/en active IP Right Grant
- 2003-03-20 CN CNA038072475A patent/CN1642525A/en active Pending
- 2003-03-20 PL PL03371295A patent/PL371295A1/en not_active Application Discontinuation
- 2003-03-20 RS YU86004A patent/RS52481B/en unknown
- 2003-03-20 NZ NZ536030A patent/NZ536030A/en not_active IP Right Cessation
- 2003-03-20 WO PCT/EP2003/002899 patent/WO2003082244A2/en active Application Filing
2004
- 2004-07-15 ZA ZA2004/05637A patent/ZA200405637B/en unknown
- 2004-09-23 NO NO20044004A patent/NO20044004L/en not_active Application Discontinuation
- 2004-09-27 HR HR20040890A patent/HRP20040890A2/en not_active Application Discontinuation
- 2004-09-28 EC EC2004005322A patent/ECSP045322A/en unknown

Also Published As

Publication number	Publication date
EA200401159A1 (en)	2005-04-28
CN1642525A (en)	2005-07-20
DE10214264A1 (en)	2003-10-16
CA2479638A1 (en)	2003-10-09
PL371295A1 (en)	2005-06-13
MXPA04009338A (en)	2005-01-25
YU86004A (en)	2006-08-17
HRP20040890A2 (en)	2005-06-30
JP5147158B2 (en)	2013-02-20
WO2003082244A3 (en)	2004-02-05
EP1492498A2 (en)	2005-01-05
JP2005527550A (en)	2005-09-15
WO2003082244A2 (en)	2003-10-09
AU2003221509A1 (en)	2003-10-13
RS52481B (en)	2013-02-28
KR101005717B1 (en)	2011-01-05
CA2479638C (en)	2011-01-04
KR20040098022A (en)	2004-11-18
ZA200405637B (en)	2005-07-27
AU2003221509B2 (en)	2008-01-24
NZ536030A (en)	2006-07-28
ECSP045322A (en)	2005-01-28
EA008610B1 (en)	2007-06-29
MEP47308A (en)	2011-02-10
UA79776C2 (en)	2007-07-25
ME00246B (en)	2011-05-10
BR0308709A (en)	2005-01-04
NO20044004L (en)	2004-10-05

Publication	Publication Date	Title
AU154703S (en)	2004-02-25	Set of trocars
EG23458A (en)	2005-10-02	Set of elements for assemlying structures
AU2003301451A1 (en)	2004-05-04	Component capable of being cooled
GB0207438D0 (en)	2002-05-08	Formulation
EP1577280A4 (en)	2006-08-23	Method of deuterization
GB0205504D0 (en)	2002-04-24	Formulation
AU2003279841A1 (en)	2004-05-04	Uses of human zven antagonists
AU2003302372A8 (en)	2004-06-18	Formulations of finasteride
PL372655A1 (en)	2005-07-25	Compositions of pentafluoropropane
IL163696A0 (en)	2005-12-18	Hfa-suspension formulation of an anhydrate
GB2388064B (en)	2005-06-08	Precise positioning of an object
PL371427A1 (en)	2005-06-13	New uses of substituted aminoalkanephosphonic acids
AU2003216848A1 (en)	2003-10-08	Deracemisation of amines
AU2003298725A8 (en)	2004-06-23	Preparation of metallotexaphyrins
AU2003267800A1 (en)	2004-05-25	Methods of using ccr1 antagonists as immunomodulatory agents
HUP0203929D0 (en)	2003-01-28	New use of substituted alkyl-piridazinone derivatives
PL356853A1 (en)	2004-05-17	Application of bacteriphages
IL165356A0 (en)	2006-01-15	Preparation of 4-haloalkylkylnicotinamides
GB0222015D0 (en)	2002-10-30	Means of assembly-bozz 2
SI1537210T1 (en)	2006-08-31	Decoy-oligonucleotide-inhbition of cd40-expression
SI1509241T1 (en)	2007-02-28	Novel uses of cephaibols
EP1511485A4 (en)	2006-04-12	Novel uses of dl-thp
GB0225040D0 (en)	2002-12-04	Formulation
GB0217078D0 (en)	2002-08-28	Formulation
GB0215589D0 (en)	2002-08-14	Formulation

Legal Events

Date	Code	Title
2013-03-24	KB	Patent renewed
2017-02-28	KB	Patent renewed
2021-03-25	KB	Patent renewed